Number of the records: 1  

Tumor-specific targeting of polymer drug delivery systems with recombinant proteins bound via tris(nitrilotriacetic acid)

  1. 1.
    SYSNO ASEP0578323
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleTumor-specific targeting of polymer drug delivery systems with recombinant proteins bound via tris(nitrilotriacetic acid)
    Author(s) Pechar, Michal (UMCH-V) RID, ORCID
    Král, Vlastimil (UOCHB-X)
    Kracíková, Lucie (UMCH-V) ORCID
    Androvič, Ladislav (UMCH-V) ORCID
    Hrdá, Eliška (UMCH-V)
    Pola, Robert (UMCH-V) RID, ORCID
    Pytlíková, Sára (UMCH-V)
    Studenovský, Martin (UMCH-V) RID, ORCID
    Kostka, Libor (UMCH-V) RID, ORCID
    Šubr, Vladimír (UMCH-V) RID, ORCID
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Kočková, Olga (UMCH-V) RID, ORCID
    Ferreira Mendes, Jessica Marianne (UOCHB-X)
    Fábry, Milan (UOCHB-X)
    Laga, Richard (UMCH-V) RID, ORCID
    Article number123619
    Source TitleInternational Journal of Pharmaceutics. - : Elsevier - ISSN 0378-5173
    Roč. 648, 15 December (2023)
    Number of pages12 s.
    Languageeng - English
    CountryNL - Netherlands
    Keywordshydrophilic polymers ; thermo-responsive polymers ; polymer drug delivery system
    Subject RIVCD - Macromolecular Chemistry
    OECD categoryPolymer science
    Subject RIV - cooperationInstitute of Organic Chemistry and Biochemistry
    R&D ProjectsLX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUMCH-V - RVO:61389013 ; UOCHB-X - RVO:61388963
    UT WOS001119134300001
    EID SCOPUS85177570270
    DOI10.1016/j.ijpharm.2023.123619
    AnnotationAntibody-mediated targeting is an efficient strategy to enhance the specificity and selectivity of polymer nanomedicines towards the target site, typically a tumor. However, direct covalent coupling of an antibody with a polymer usually results in a partial damage of the antibody binding site accompanied with a compromised biological activity. Here, an original solution based on well-defined non-covalent interactions between tris-nitrilotriacetic acid (trisNTA) and hexahistidine (His-tag) groups, purposefully introduced to the structure of each macromolecule, is described. Specifically, trisNTA groups were attached along the chains of a hydrophilic statistical copolymer based on N-(2-hydroxypropyl)methacrylamide (HPMA), and at the end or along the chains of thermo-responsive di-block copolymers based on N-isopropylmethacrylamide (NIPMAM) and HPMA. His-tag was incorporated to the structure of a recombinant single chain fragment of an anti-GD2 monoclonal antibody (scFv-GD2). Static and dynamic light scattering analyses confirmed that mixing of polymer with scFv-GD2 led to the formation of polymer/scFv-GD2 complexes. Those prepared from thermo-responsive polymers formed stable micelles at 37 °C. Flow cytometry and fluorescence microscopy clearly demonstrated antigen-specific binding of the prepared complexes to GD2 positive murine T-cell lymphoma cells EL-4 and human neuroblastoma cells UKF-NB3, while no interaction with GD2 negative murine fibroblast cells NIH-3T3 was observed. These non-covalent polymer protein complexes represent a new generation of highly specific actively targeted polymer therapeutics or diagnostics.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2024
    Electronic addresshttps://www.sciencedirect.com/science/article/pii/S0378517323010414?via%3Dihub
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.